The STATinMED team is thrilled to once again participate in the upcoming European Society of Cardiology (ESC) Congress 2021. Our team co-authored 7 poster presentations on topics assessing patient outcomes among those diagnosed with atrial fibrillation and venous thromboembolism.

Poster Presentations

      • Time at home among nonvalvular atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants vs warfarin
      • Time at home among nonvalvular atrial fibrillation patients treated with non-vitamin K antagonist oral anticoagulants: An ARISTOPHANES analysis
      • Effectiveness and safety of non-vitamin K antagonist oral anticoagulants among nonvalvular atrial fibrillation patients with prior bleeding events
      • Effectiveness and safety of non-vitamin K antagonist oral anticoagulants vs warfarin among nonvalvular atrial fibrillation patients with prior bleeding events
      • Effectiveness and safety of apixaban vs warfarin among older venous thromboembolism patients: A subgroup analysis of age
      • Effectiveness and safety of apixaban vs warfarin among venous thromboembolism patients using five US databases: A subgroup analysis of chronic liver disease
      • Effectiveness and safety of apixaban vs warfarin among older venous thromboembolism patients stratified by race

Learn more about our resources

ESC Congress 2021 Abstracts